175 filings
6-K
GNFT
Genfit S.A.
19 Sep 24
Current report (foreign)
4:12pm
6-K
GNFT
Genfit S.A.
19 Sep 24
GENFITÂ Reports First Half-Year 2024 Financial Results and Provides Corporate Update
4:10pm
6-K
GNFT
Genfit S.A.
26 Jul 24
Current report (foreign)
8:32am
6-K
GNFT
Genfit S.A.
9 Jul 24
Current report (foreign)
4:10pm
6-K
GNFT
Genfit S.A.
17 Jun 24
Current report (foreign)
4:10pm
6-K
dl2opype9wk4ivc
10 Jun 24
Current report (foreign)
5:59pm
6-K
nyc5mjktm2w
29 May 24
GENFIT to Present Latest ACLF Research at EASL Congress™ 2024
4:10pm
6-K
nkb30p0elu4
22 May 24
Current report (foreign)
12:06pm
6-K
54jw2e9
14 May 24
GENFIT Reports First Quarter 2024 Financial Information
4:10pm
6-K
sp8hegy
25 Apr 24
Current report (foreign)
4:10pm
6-K
2vyu7gidhdly
15 Apr 24
Current report (foreign)
4:10pm
6-K
1cs98qm5
5 Apr 24
GENFIT Announces Publication of the 2023 Universal Registration Document and the 2023 Annual Report on Form 20-F
2:03pm
6-K
5nfjhbx 58v9ejrj
4 Apr 24
GENFIT Reports Full-Year 2023 Financial Results and Provides Corporate Update
4:45pm
6-K
0xyrlgr8vab
29 Feb 24
Current report (foreign)
4:10pm
SC 13G/A
29z6s7 smfwkmvbpjdr
14 Feb 24
Genfit / TANG CAPITAL PARTNERS ownership change
4:00pm
6-K
nl8qotmdsd6j
17 Jan 24
GENFIT Announces 2024 Financial Calendar
6:00am
6-K
0qfh9thg
11 Jan 24
Current report (foreign)
4:10pm
6-K
8a0cgga2v53
8 Dec 23
Current report (foreign)
8:00am
6-K
i2p ycm5wu8n2
7 Dec 23
Ipsen confirms U.S. FDA grants priority review for New Drug Application for elafibranor for the treatment of rare cholestatic liver disease, PBC
6:37am